AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.90
-0.50 (-4.39%)
At close: Oct 13, 2026, 4:00 PM EDT
10.90
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:10 PM EDT
AngioDynamics Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 325.38 | 320.17 | 292.5 | 303.91 | 338.75 | 316.22 | |
Revenue Growth | 8.20% | 9.46% | -3.76% | -10.28% | 7.13% | 8.66% |
Cost of Revenue | 145.5 | 145.28 | 134.79 | 149.22 | 164.51 | 150.49 |
Gross Profit | 179.88 | 174.89 | 157.71 | 154.7 | 174.25 | 165.73 |
Selling, General & Admin | 159.44 | 157.61 | 145.6 | 144.18 | 144.45 | 134.01 |
Research & Development | 30.43 | 28.93 | 25.85 | 31.32 | 29.69 | 30.48 |
Amortization of Goodwill & Intangibles | 10.76 | 10.68 | 10.32 | 13.05 | 18.79 | 19.46 |
Other Operating Expenses | 0.14 | 0.14 | -0.49 | 0.11 | 0.63 | - |
Operating Expenses | 200.77 | 197.36 | 181.27 | 188.66 | 193.56 | 183.95 |
Operating Income | -20.89 | -22.47 | -23.57 | -33.96 | -19.31 | -18.22 |
Interest Expense | -0.38 | -0.3 | - | - | -2.7 | -0.69 |
Interest & Investment Income | - | - | 0.98 | 1.61 | - | - |
Other Non Operating Income (Expenses) | 4.2 | 3.93 | 4.94 | -0.82 | -0.55 | -0.79 |
EBT Excluding Unusual Items | -17.08 | -18.84 | -17.65 | -33.16 | -22.57 | -19.7 |
Merger & Restructuring Charges | -12.09 | -13.82 | -15.4 | -18.13 | -1.46 | -0.7 |
Impairment of Goodwill | - | - | - | -159.48 | -14.55 | - |
Gain (Loss) on Sale of Assets | - | - | - | 54.5 | - | - |
Legal Settlements | -2.21 | -2.01 | -0.72 | -34.94 | -10 | -7.63 |
Other Unusual Items | -1.39 | -1.63 | -0.27 | -0.43 | -5.86 | -1.93 |
Pretax Income | -32.76 | -36.3 | -34.03 | -191.64 | -54.44 | -29.95 |
Income Tax Expense | 0.18 | 0.44 | -0.04 | -7.29 | -2 | -3.4 |
Earnings From Continuing Operations | -32.94 | -36.74 | -33.99 | -184.35 | -52.44 | -26.55 |
Net Income | -32.94 | -36.74 | -33.99 | -184.35 | -52.44 | -26.55 |
Net Income to Common | -32.94 | -36.74 | -33.99 | -184.35 | -52.44 | -26.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 42 | 42 | 41 | 40 | 39 | 39 |
Shares Outstanding (Diluted) | 42 | 42 | 41 | 40 | 39 | 39 |
Shares Change | 1.84% | 1.65% | 1.67% | 1.78% | 1.21% | 1.74% |
EPS (Basic) | -0.79 | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 |
EPS (Diluted) | -0.79 | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | 1.44 | 0.51 | -14.59 | -30.68 | -3.73 | -11.49 |
Free Cash Flow Per Share | 0.04 | 0.01 | -0.36 | -0.76 | -0.10 | -0.29 |
Gross Margin | 55.28% | 54.62% | 53.92% | 50.90% | 51.44% | 52.41% |
Operating Margin | -6.42% | -7.02% | -8.06% | -11.17% | -5.70% | -5.76% |
Profit Margin | -10.12% | -11.48% | -11.62% | -60.66% | -15.48% | -8.39% |
Free Cash Flow Margin | 0.44% | 0.16% | -4.99% | -10.09% | -1.10% | -3.63% |
EBITDA | 1.31 | 0.19 | -1.17 | -8.65 | 11.56 | 11.13 |
EBITDA Margin | 0.40% | 0.06% | -0.40% | -2.84% | 3.41% | 3.52% |
D&A For EBITDA | 22.2 | 22.66 | 22.4 | 25.31 | 30.87 | 29.35 |
EBIT | -20.89 | -22.47 | -23.57 | -33.96 | -19.31 | -18.22 |
EBIT Margin | -6.42% | -7.02% | -8.06% | -11.17% | -5.70% | -5.76% |